Travellers returning with measles from Thailand to Finland, April 2012: Infection control measures

Eurosurveillance

Volumn 17, Issue 22, 2012, Pages

  Kantele, A ^a,b   Valtonen, K ^c   Davidkin, I ^c   Martelius, T ^a   Vozelevskaja N ^d   Skogberg, K ^a   Liesmaa, I ^a   Lyytikainen O ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Northern Service of the Health Board   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; MEASLES MUMPS RUBELLA VACCINE;

ADULT; ARTICLE; CASE REPORT; CONTACT EXAMINATION; COUGHING; FEMALE; FEVER; FINLAND; HUMAN; IMPORT DISEASE; INFECTION CONTROL; MEASLES; MEASLES VIRUS; POLYMERASE CHAIN REACTION; POST EXPOSURE PROPHYLAXIS; RASH; SNEEZING; THAILAND;

EID: 84863113851     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.17.22.20184-en     Document Type: Article

References (13)

1. Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153-164.
2. Muscat M, Bang H, Wohlfahrt J, Glismann S, Mølbak K; EUVAC.NET Group. Measles in Europe: an epidemiological assessment. Lancet. 2009;373(9661):383-389.
3. Davidkin I, Kontio M, Paunio M, Peltola H. MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines. 2010;9(9):1045-1053.
4. National Institute for Health and Welfare (THL). Toimenpideohje torjuntatoimista tuhkarokkotapauksen yhteydessä. [Guidelines for infection control measures against measles]. Helsinki: THL; 7 June 2011. Finnish. Available from: http://www.thl.fi/thl-client/pdfs/0adda5d0-d43f-4ed6-ad4c-e0d9a330da14
5. Tharmaphornpilas P, Yoocharean P, Rasdjarmrearnsook AO, Theamboonlers A, Poovorawan Y. Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme. J Health Popul Nutr. 2009:27(1):80-86.
6. Official Statistics of Finland (OSF): Finnish travel. Helsinki: Statistics Finland. [Acccessed 28 May 2012]. Available from: http://www.stat.fi/til/smat/index_en.html
7. ProMED-mail. [Measles (outbreak - 47 cases) - Russia (Udmurtia) (4)]. Archive Number 20120515.142692. 15 May 2012. Russian. Available from: http://www.promedmail.org/direct.php?id=20120515.142692
8. Gustafson TL, Lievens AW, Brunell PA, Moellenberg RG, Buttery CM, Sehulster LM. Measles outbreak in a fully immunized secondary-school population. N Engl J Med. 1987;316(13):771-774.
9. Mathias RG, Meekison WG, Arcand TA, Schechter MT. The role of secondary vaccine failures in measles outbreaks. Am J Public Health. 1989;79(4):475-478.
10. Hirose M, Hidaka Y, Miyazaki C, Ueda K, Yoshikawa H. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination. Scand J Infect Dis. 1997;29(2):187-190.
11. Reyes MA, de Borrero MF, Roa J, Bergonzoli G, Saravia NG. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J. 1987;6(9):848-851.
12. Smith FR, Curran AS, Raciti KA, Black FL. Reported measles in persons immunologically primed by prior vaccination. J Pediatr. 1982;101(3):391-393.
13. Kremer JR, Schneider F, Muller CP. Waning antibodies in measles and rubella vaccinees-a longitudinal study. Vaccine. 2006;24(14):2594-2601.